| [1] |
Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]．C A Cancer J Clin, 2011, 61(2): 69-90.
|
| [2] |
Li S, Hu T, Lyu W，et al.Changes in prevalence and clinical characteristics of cervical cancer in the People′s Republic of China：a study of 10 012 cases from a nationwide working group[J]. Oncologist，2013, 18(10): 1101-1107.
|
| [3] |
谢幸，苟文丽，林仲秋,等．妇产科学[M]. 北京：人民卫生出版社，2013: 301.
|
| [4] |
罗新，范瑾. hTERC基因检测技术在宫颈病变筛查中的地位[J]．中国计划生育和妇产科,2013, 5(3): 5-8.
|
| [5] |
钱新宇，韩焕兴. 肿瘤发生学与肿瘤的临床防治[J]. 肿瘤研究及临床，2008, 20(4): 217-220.
|
| [6] |
陈悦，张晓薇，邓志校，等. P16基因表达与宫颈癌预后相关性分析[J]．实用医学杂志,2014, 30(15)：2417-2420.
|
| [7] |
Travis J. Closing in on melanoma susceptibility gene(s)[J]. Science, 1992, 258(5085): 1080-1081.
|
| [8] |
杨军，黄小钟，郭睿，等．P16INK4a蛋白可作为乳腺癌特异性分子标志[J]．南方医科大学学报，2016, 36(6): 751-755.
|
| [9] |
董晓刚，郭文佳，丁伟．p16、RASSF1A在肝细胞性肝癌患者肿瘤组织及血浆中异常甲基化的检测及临床意义[J]．中国医药生物技术，2016, 11(3): 252-258.
|
| [10] |
Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4[J]. Nature, 1993, 366(6456): 704-707.
|
| [11] |
Hsieh R, Firmiano A, Sotto MN. Expression of p16 protein in acral lentiginous melanoma[J]. Int J Dermatol, 2009，48(12): 1303-1307.
|
| [12] |
Samir R, Asplund A, Tot T, et al. High-risk HPV infection and CIN grade correlates to the expression of c-myc, CD4+HIT, E-cadherin, Ki-67, and p16INK4a[J]. J Low Genit Tract Dis, 2011, 15(4): 280-286.
|
| [13] |
Carozzi F, Gillio-Tos A, Confortini M, et al. Risk of high-grade cervical intraepithelial neoplastic during follow-up in HPV-positive women according to baseline P16-INK4A results: a prospective analyses of a nested sub-study of the NTCC randomized controlled trial[J]．Lancet Onco1, 2013, 14(2)：168-176.
|
| [14] |
Negri G, Bellisano G, Zannoni GF, et al. p16 ink4a and HPV L1 immunohistochemistry is helpful for estimating the behavior of low-grade dysplastic lesions of the cervix uteri[J]. Am J Surg Pathol, 2008, 32(11): 1715-1720.
|
| [15] |
Yildiz IZ, Usubütün A, Firat P, et al. Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature[J]. Pathol Res Pract, 2007, 203(6): 445-449.
|
| [16] |
O′Neill CJ, McCluggege WG.p16 expression in the female genital tract and its value in diagnosis[J]．Adv Anat Pathol，2006，13(1): 8-15.
|
| [17] |
Hilfrich R, Hariri J. Prognostic relevance of human papillomavirus L1 capsid protein detection within mild and moderate dysplastic lesions of the cervix uteri in combination with p16 biomarker[J]. Anal Quant Cytol Histol, 2008, 30(2): 78-82.
|
| [18] |
宋艳，李凌，李青，等. Ll壳蛋白和p16INK4a蛋白在不同类型宫颈上皮内瘤变1级中的表达意义[J]．中国药物与临床，2012，12(6)：741-743.
|
| [19] |
罗阳刚，吕玉宇．HPV L1壳蛋白与P16蛋白联合检测在宫颈癌前病变中的临床意义[J]．检验医学与临床，2015，12(22)：3314-3317.
|
| [20] |
Kuo SH, Chou CH, Cheng AL, et al. Expression of BCL10 in cervical cancer has a role in the regulation of cell growth through the activation of NF-κB-dependent cyclin D1 signaling[J]. Gynecol Oncol, 2012, 126(2): 245-251.
|
| [21] |
Wan Q, Zheng A, Liu X, et al. Expression of transient receptor potential channel 6 in cervical cancer[J]. Oncotarget Ther, 2011, 5(4): 171-176.
|
| [22] |
Kim TY, Vigil D, Der CJ, et al. Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motility[J]. Cancer Metastasis Rev, 2009, 28(1-2): 77-83.
|
| [23] |
齐朝阳，陈艳，曾鸿，等．宫颈上皮内肿瘤P16、P53、Ki67、P63的表达与HPV感染及其临床意义[J]. 实用医学杂志，2011，27(20): 3638-3640.
|
| [24] |
Chew I, Post MD, Carinelli SG, et al. p16 expression in squamous and trophoblastic lesions of the upper female genital tract[J]. Int J Gynecol Pathol, 2010, 29(6): 513-522.
|
| [25] |
Sahebali S, Depuydt CE, Boulet GA, et al. Immunocytochemistry in liquid-based cervical cytology: analysis of clinical use following a cross-sectional study[J]. Int J Cancer, 2006, 118(5): 1254-1260.
|
| [26] |
Eleutério Jr, Giraldo PC, Gonçalves AK, et al. Prognostic markers of high-grade squamous intraepithelial lesions: the role of p16INK4a and high-risk human papillomavirus[J]. Acta Obstet Gynecol Scand, 2007, 86(1): 94-98.
|
| [27] |
Mulvany NJ, Allen DG, Wilson SM. Diagnostic utility of p16INK4a: a reappraisal of its use in cervical biopsies[J]. Pathology, 2008, 40(4): 335-344.
|
| [28] |
Darragh TM, Colgan TJ, Thomas CJ, et al. The Lower Anogenital Squamous Terminology Standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology[J]. Int J Gynecol Pathol, 2013, 32(1)：76-115.
|
| [29] |
Negri G, Egarter-Vigl E, Kasal A, et al. p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations[J]. Am J Surg Pathol, 2003, 27(2): 187-193.
|
| [30] |
罗阳刚，吕玉宇. HPV L1壳蛋白与P16蛋白联合检测在宫颈癌前病变中的临床意义[J]. 检验医学与临床，2015，12(22)：3314-3317.
|
| [31] |
Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer[J]. Clin Sci (Lond), 2006, 110(5): 525-541.
|
| [32] |
范江涛,陈心秋,张卉. 表达HPV16L1、L2和E7蛋白的非复制重组痘苗病毒诱发的抗肿瘤免疫反应[J]．中国免疫学杂志，2009，25(4)：317-320.
|
| [33] |
Pinto LA, Viscidi R, Harro CD, et al. Cellular immune responses to HPV-18, -31, and -53 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles[J]．Virology, 2006, 353(2)：451-462.
|